Clinical trial
Efficacy and Safety of Golimumab in the Treatment of Refractory Uveitis in Patients With Behcet's Disease
NCT04218565 is registered in ClinicalTrials.gov with Wenjie Zheng as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Efficacy and Safety of Golimumab in the Treatment of Refractory Uveitis in Patients With Behcet's Disease
- Lead sponsor
- Wenjie Zheng
- Phase
- Phase 2
- Overall status
- Terminated
- Start date
- February 15, 2020
- Completion date
- December 15, 2022
- Enrollment
- 1 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.